Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance.

Journal:

Hepatology

Published:

2025-11-08

DOI:

10.1097/hep.0000000000001608

Affiliations:

9

Authors:

6

Go to article

Institutions	Authors	Share
Mayo Clinic, United States of America (USA)	1.000000	0.17
UW Medicine, United States of America (USA)	1.000000	0.17
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	1.000000	0.17
VA Long Beach Healthcare System, United States of America (USA)	0.500000	0.08
VA San Diego Healthcare System, United States of America (USA)	0.500000	0.08
UC San Diego Health Sciences, United States of America (USA)	0.500000	0.08
VA Connecticut Healthcare System, United States of America (USA)	0.500000	0.08
University of California, Irvine (UCI), United States of America (USA)	0.500000	0.08
Yale University, United States of America (USA)	0.500000	0.08

Interested in Clinical Sciences?